InvestorsHub Logo
Followers 7
Posts 662
Boards Moderated 0
Alias Born 05/23/2015

Re: 236T568 post# 1400

Thursday, 03/30/2017 10:41:23 AM

Thursday, March 30, 2017 10:41:23 AM

Post# of 2432
yeah, it's one of the weirdest PR's I have ever read.

"The Company found that cannabidiol (CBD) universally inhibited cell growth at concentrations similar to established chemotherapeutics."

a general statement. has nothing to do with VBIO's product. also, no details on what research was done, under what conditions, etc.

"Vitality also found that its cannabidiol prodrug was not toxic to the human cells at the concentrations tested, demonstrating the relative safety of its prodrug delivery system.

and then a statement on its own drug, saying it is "relatively safe". whether it actually works isn't clear, as the first statement and the second statement seem to have no relation to each other.

and lets not forget, VBIO's "drug" (whatever that may be) needs to undergo three FDA-regulated phases, costing millions and millions and millions of dollars the company currently doesn't have, and years and years of research.

is VBIO actually interested in doing that, or are they in the business of sending out riduclous press releases with weird claims that are unsubstantiated and bear no actual significance to VBIO's own IP?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RNGE News